A reasonable chance it could cause serious harm or death.
Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength.
| Brand name | CLONAZEPAM |
| Generic name | CLONAZEPAM |
| Active ingredient(s) | CLONAZEPAM |
| Distributed by / for | PAR Pharmaceutical, Chestnut Ridge, NY 10977 |
| NDC | 49884-309-02 |
| Full product label | Clonazepam Orally Disintegrating Tablets, USP, 1 mg, C-IV, Rx Only, 60 tablets per carton (10 blister cards containing 6 tablets each), Distributed by: PAR Pharmaceutical, Chestnut Ridge, NY 10977, NDC#: 49884-309-02 (carton), NDC #: 49884-309-52 (blisters). |
| Recalling firm | Endo USA, Inc. |
| Distribution | Nationwide in the USA |
| Quantity | 22,513 cartons |
| Recall initiated | 2024-11-18 |
| Report date | 2025-01-15 |
| Recall completed | — |
| Recall number | D-0181-2025 |
| Classification | Class I |
| FDA status | Ongoing |
| Origin on file | Malvern PA United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗